Global Vision. Local Expertise.
Trusted Partners

Cross-border M&A, licensing & partnership, financial and strategic financial advisory for the healthcare sector—connecting strategy, capital, and deep industry expertise

Our Services

About CHC Capital Partners

Boutique healthcare advisory firm delivering M&A, licensing & partnership, financial and strategic advisory across global healthcare markets

Healthcare-Focused, Trusted Partners

CHC Capital Partners focuses exclusively on healthcare M&A, biotech and biopharma licensing & partnership, financial and strategic advisory for the global healthcare industry

We bring specialized expertise across pharma, biotech, medtech, IVD, consumer health, healthtech, and healthcare services, with a deep understanding of regulatory environments, market dynamics, and valuation complexities unique to healthcare

Senior partners lead every engagement from pitch to close, bringing decades of healthcare-specific expertise

With a proven track record across Europe, North America, and Asia-Pacific healthcare markets, we partner with pharmaceutical companies, biotech innovators, medtech firms, and healthcare investors to execute complex, high-value transactions and create lasting value

Business professionals in meeting
15+

Years Healthcare Experience

100+

Active Assets

$5B+

Live Mandates Value

18

Healthcare Markets

Our Healthcare Services

Specialized advisory services for the global healthcare industry

Mergers & Acquisitions

End-to-end M&A advisory for healthcare companies, including buy-side and sell-side mandates, cross-border transactions, and strategic partnerships

Licensing & Partnerships

Bridging parties, facilitating introductions and negotiations, and advising on licensing agreements, co-development partnerships, and commercial collaborations for biotech and pharmaceutical assets

Strategic Advisory

Market entry strategies, portfolio optimization, growth planning, and transaction support for healthcare companies across all sectors

Financial Advisory

Valuation analysis, financial modeling, and transaction structuring tailored to healthcare industry dynamics, alongside access to UK and European family offices and private capital—helping founders align strategy, financials, and investor expectations (excluding regulated securities activities).

Valuation & Due Diligence

Healthcare-specific company and asset valuation, commercial due diligence, and market analysis for transactions and strategic decision-making

Joint Ventures

Structuring and advising on cross-border joint ventures and strategic alliances in regulated healthcare markets

Healthcare Industry Focus

Deep sector expertise across the healthcare landscape

Pharmaceuticals

M&A, licensing, strategic advisory for companies ranging from Big Pharma to specialty and emerging pharma, across branded, generic, and specialty portfolios.

Biotechnology

Partnerships, licensing, M&A, strategic, and financial advisory for biotech companies across therapeutic areas and development stages, including AI-driven drug discovery platforms and next-generation R&D technologies.

MedTech

M&A, strategic, and financial advisory for medical device and diagnostic companies, including In Vitro Diagnostics (IVD) such as molecular diagnostics, point-of-care testing, companion diagnostics, and laboratory instruments.

HealthTech & AI-Healthcare & Digital Health

M&A, strategic, and financial advisory for technology-enabled healthcare companies, including AI-powered clinical decision support, medical imaging AI, digital therapeutics, remote monitoring, healthcare IT, workflow automation, and data-driven care delivery platforms.

Consumer Health

M&A and financial advisory for OTC, nutraceutical, wellness, preventive health, and personal care companies, spanning science-backed and brand-led models.

Healthcare Services

M&A, strategic, and financial advisory for providers, CROs, CDMOs, diagnostics services, and other healthcare service organizations, supporting scale-up, consolidation, and value creation.

Disclaimer: CHC Capital Partners provides corporate, strategic, and financial advisory services exclusively. We do not provide regulated investment advice, securities dealing, or asset management services as defined by the UK Financial Conduct Authority (FCA) or the Hong Kong Securities and Futures Commission (SFC).

Our People

Senior partners with top-tier global healthcare experience

New York City skyline

Senior-led, partner-focused

Extensive global network of executives at Big Pharma and MedTech companies, entrepreneurs in biotech, health-tech, and healthcare services, and healthcare investors

  • Former executives from top-tier investment banks, MBB firms, and global healthcare corporates
  • Average of 15+ years of healthcare advisory, investment, and industry experience
  • Extensive global network of executives at Big Pharma and MedTech companies, entrepreneurs in biotech, health-tech, and healthcare services, and healthcare investors
  • Multilingual professionals with deep expertise in cross-border healthcare markets
Learn More

Contact Us

For confidential discussions please reach out to schedule a director-level call

 Send us an email

We'll respond within 48 hours

 +44 20 4577 0383

London, UK

 Our Presence

London, Hong Kong, Boston, Shanghai

Global Vision. Local Expertise. Trusted Partners

Excellence in Healthcare M&A & Strategic Advisory